Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biogen (BIIB)
NASDAQ:BIIB
BIIB Analyst Ratings
Moderate Buy
12 Buy
13 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BIIB Stock 12 Month Forecast
Average Price Target
$191.86
▲(39.71% Upside)
| Highest Price Target$265.00 | Average Price Target$191.86 | Lowest Price Target$135.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Reiterated
02/18/25
Bernstein
Reiterated
02/18/25
Leerink Partners
Reiterated
02/13/25
Wells Fargo
Reiterated
02/13/25
Wedbush
Reiterated
02/13/25
Bank of America Securities
Reiterated
02/13/25
Truist Financial
Reiterated
02/13/25
Scotiabank
Reiterated
02/13/25
Evercore ISI
Reiterated
02/13/25
Goldman Sachs
Reiterated
02/12/25
Morgan Stanley
$192→$157
Hold
14.32%
Upside
Reiterated
02/12/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (NASDAQ: IRTC), Vir Biotechnology (NASDAQ: VIR) and Biogen (NASDAQ: BIIB)
BMO Capital
$156
Hold
13.59%
Upside
Downgraded
02/12/25
Cautious Outlook on Biogen Amid Declining MS Revenues and Uncertain Growth Prospects
H.C. Wainwright
$300→$241
Buy
75.49%
Upside
Reiterated
02/12/25
Biogen price target lowered to $241 from $300 at H.C. WainwrightBiogen price target lowered to $241 from $300 at H.C. Wainwright
Needham
―
Hold
―
Reiterated
02/12/25
Biogen's Mixed Financial Outlook: Hold Rating Amid Strong Q4 Performance and Future EPS Decline
TD Cowen
$275→$200
Buy
45.63%
Upside
Reiterated
02/12/25
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (NASDAQ: ORIC) and Biogen (NASDAQ: BIIB)
Best Analysts Covering Biogen
Which Analyst Should I Follow If I Want to Buy BIIB and Sell After:
1 Month
xxx
Success Rate
15/33 ratings generated profit
Average Return
<+0.01%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 45.45% of your transactions generating a profit, with an average return of <+0.01% per trade.
3 Months
xxx
Success Rate
16/33 ratings generated profit
Average Return
-1.76%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.48% of your transactions generating a profit, with an average return of -1.76% per trade.
1 Year
Success Rate
11/39 ratings generated profit
Average Return
-7.75%
reiterated a buy rating 6 days ago
Copying Marc Goodman's trades and holding each position for 1 Year would result in 28.21% of your transactions generating a profit, with an average return of -7.75% per trade.
2 Years
xxx
Success Rate
9/36 ratings generated profit
Average Return
-21.31%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -21.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BIIB Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
14
17
16
9
12
Buy
29
17
9
3
6
Hold
18
21
22
21
25
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
61
55
47
33
43
Each month's total comprises the sum of three months' worth of ratings.
BIIB Financial Forecast
BIIB Stock Forecast FAQ
What is BIIB’s average 12-month price target, according to analysts?
Based on analyst ratings, Biogen’s 12-month average price target is $191.86.
What is BIIB’s upside potential, based on the analysts’ average price target?
Biogen has 39.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BIIB a Buy, Sell or Hold?
Biogen has a consensus rating of Moderate Buy which is based on 12 buy ratings, 13 hold ratings and 0 sell ratings.
What is Biogen’s price target?
The average price target for Biogen is $191.86. This is based on 25 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $265.00 ,the lowest forecast is $135.00. The average price target represents 39.71% Increase from the current price of $137.33.
The highest analyst price target is $265.00 ,the lowest forecast is $135.00. The average price target represents 39.71% Increase from the current price of $137.33.
What do analysts say about Biogen?
Biogen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 25 Wall Streets Analysts.
How can I buy shares of BIIB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.